Celiac test kits match multi-centre study demands

The results of the recent Multi-Centre Celiac Serology Study undertaken to define the optimal serological screening approach to Celiac Disease clearly showed that dual or combined isotype (IgA+IgG) transglutaminase screening can be advocated as a sensitive and specific alternative to endomysial antibody testing in the assessment of Celiac Disease.

The manufacturer Aesku Diagnotics reports that its AESKULISA tTg ELISA kits ‘performed excellently’, and the AESKULISA Celicheck was ‘even placed first as the best dual isotype transglutaminase kit of all assays tested.’ The Elisa kits have a unique composition, the firm explains. ‘Human recombinant tissue transglutaminase is cross-linked with gliadin-specific peptides resulting in the creation of neo-epitopes of tTg. The tests are highly specific as no cross-reactions with gliadin occur.’
* The FDA has approved the improved Aeskulisa tTg IgA and tTg IgG tests for the detection of tissue transglutaminase (tTg) antibodies.
 

20.11.2008

More on the subject:

Related articles

Photo

Sponsored • Produced in partnership with FUJIFILM Wako

Beta-D-glucan testing: More than a single result

Invasive fungal infections remain among the most challenging diagnoses in clinical microbiology. Beta-D-glucan (BDG) testing has emerged as a valuable non-invasive biomarker – but its true utility…

Photo

Interview • Resilience in healthcare

“We need redundancy at every level”

The threat of hybrid attacks in Germany is increasing. In this exclusive interview with MedLabPortal, DGKL CEO Jan Wolter highlights existing vulnerabilities and calls on policymakers to take action.

Photo

News • Acute myeloid leukaemia

Six-gene scoring system could help predict AML survival

Acute myeloid leukaemia (AML) has widely variable outcomes from one patient to the next. Now, researchers have created a new scoring system based on the activity of six different genes to help…

Subscribe to Newsletter